Cantargia: Nadunolimab Soon Ready for Leukaemia Trial - Redeye
Cantargia today reported the preparations for the clinical trial of nadunolimab in leukaemia is going according to plan. The trial is scheduled to commence this summer.
ANNONS
Cantargia today reported the preparations for the clinical trial of nadunolimab in leukaemia is going according to plan. The trial is scheduled to commence this summer.